Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 3

Results: 16

Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 419, doi. 10.1007/s00262-010-0930-1

By:

Ramakrishnan, Rupal;
Gabrilovich, Dmitry

Publication type:

Article

A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 327, doi. 10.1007/s00262-010-0938-6

By:

Rogel, Anne;
Vignard, Virginie;
Bobinet, Mathilde;
Labarriere, Nathalie;
Lang, François

Publication type:

Article

In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 339, doi. 10.1007/s00262-010-0937-7

By:

Shen, Guodong;
Huang, Hui;
Zhang, Anli;
Zhao, Ting;
Hu, Siyi;
Cheng, Liansheng;
Liu, Jing;
Xiao, Weihua;
Ling, Bin;
Wu, Qiang;
Song, Lihua;
Wei, Wei

Publication type:

Article

Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 305, doi. 10.1007/s00262-011-0974-x

By:

Terpos, Evangelos;
Dimopoulos, Meletios

Publication type:

Article

Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 371, doi. 10.1007/s00262-010-0950-x

By:

Roider, Elisabeth;
Jellbauer, Stefan;
Köhn, Brigitte;
Berchtold, Christina;
Partilla, Miriam;
Busch, Dirk;
Rüssmann, Holger;
Panthel, Klaus

Publication type:

Article

Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 349, doi. 10.1007/s00262-010-0939-5

By:

Yi, Huanfa;
Yu, Xiaofei;
Guo, Chunqing;
Manjili, Masoud;
Repasky, Elizabeth;
Wang, Xiang-Yang

Publication type:

Article

Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 413, doi. 10.1007/s00262-010-0944-8

By:

Dhodapkar, Madhav;
Dhodapkar, Kavita

Publication type:

Article

Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 361, doi. 10.1007/s00262-010-0945-7

By:

Li, Haishan;
Pauza, C.

Publication type:

Article

Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 401, doi. 10.1007/s00262-010-0956-4

By:

Domschke, Christoph;
Schuetz, Florian;
Ge, Yingzi;
Rom, Joachim;
Zorn, Markus;
Sinn, Hans-Peter;
Marmé, Frederik;
Schott, Sarah;
Heil, Joerg;
Scharf, Alexander;
Sohn, Christof;
Schneeweiss, Andreas;
Beckhove, Philipp

Publication type:

Article

CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26-28, 2010, Mainz, Germany.

Published in:

2011

By:

Singh, Satwinder;
Laske, Karoline;
Gouttefangeas, Cécile;
Britten, Cedrik;
Welters, Marij

Publication type:

Report

Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 433, doi. 10.1007/s00262-010-0960-8

By:

Disis, Mary

Publication type:

Article

Suppression of T-cell responses by tumor metabolites.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 425, doi. 10.1007/s00262-010-0967-1

By:

Singer, Katrin;
Gottfried, Eva;
Kreutz, Marina;
Mackensen, Andreas

Publication type:

Article

Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 389, doi. 10.1007/s00262-010-0949-3

By:

Maglioco, Andrea;
Machuca, Damián;
Mundiñano, Juliana;
Cabrera, Gabriel;
Camicia, Gabriela;
Bruzzo, Juan;
Camerano, Gabriela;
Costa, Héctor;
Ruggiero, Raúl;
Dran, Graciela

Publication type:

Article

Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 381, doi. 10.1007/s00262-010-0948-4

By:

Wang, Adele;
Crome, Sarah;
Jenkins, Kristina;
Medin, Jeffrey;
Bramson, Jonathan;
Levings, Megan

Publication type:

Article

2011: the immune hallmarks of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 319, doi. 10.1007/s00262-010-0968-0

By:

Cavallo, Federica;
De Giovanni, Carla;
Nanni, Patrizia;
Forni, Guido;
Lollini, Pier-Luigi

Publication type:

Article

Acknowledgement.

Published in:: Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 451, doi. 10.1007/s00262-011-0983-9
Publication type:: Article